AT-04

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameAT-04
Drug Alias NameAT-04
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionPhagocytes stimulantsImmunoglobulin G inhibitors
TargetsImmunoglobulin G
Therapy Area/IndicationsAmyloidosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAttralus Inc
China Registration ClassN/A

Develop Information

Active CompaniesAttralus Inc
Inactive CompaniesN/A
Active IndicationsAmyloidosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A